These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22014751)

  • 1. Design, synthesis and biological evaluation of nuclear receptor-degradation inducers.
    Itoh Y; Kitaguchi R; Ishikawa M; Naito M; Hashimoto Y
    Bioorg Med Chem; 2011 Nov; 19(22):6768-78. PubMed ID: 22014751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins.
    Itoh Y; Ishikawa M; Naito M; Hashimoto Y
    J Am Chem Soc; 2010 Apr; 132(16):5820-6. PubMed ID: 20369832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of target protein-selective degradation inducer for protein knockdown.
    Itoh Y; Ishikawa M; Kitaguchi R; Sato S; Naito M; Hashimoto Y
    Bioorg Med Chem; 2011 May; 19(10):3229-41. PubMed ID: 21515062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands.
    Shibata N; Nagai K; Morita Y; Ujikawa O; Ohoka N; Hattori T; Koyama R; Sano O; Imaeda Y; Nara H; Cho N; Naito M
    J Med Chem; 2018 Jan; 61(2):543-575. PubMed ID: 28594553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptor drug discovery.
    Chen T
    Curr Opin Chem Biol; 2008 Aug; 12(4):418-26. PubMed ID: 18662801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific non-genetic IAP-based protein erasers (SNIPERs) as a potential therapeutic strategy.
    Ma Z; Ji Y; Yu Y; Liang D
    Eur J Med Chem; 2021 Apr; 216():113247. PubMed ID: 33652355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy.
    Ohoka N; Shibata N; Hattori T; Naito M
    Curr Cancer Drug Targets; 2016; 16(2):136-46. PubMed ID: 26560118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising core structure for nuclear receptor ligands: design and synthesis of novel estrogen receptor ligands based on diphenylamine skeleton.
    Ohta K; Chiba Y; Ogawa T; Endo Y
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5050-3. PubMed ID: 18760603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein.
    Okuhira K; Ohoka N; Sai K; Nishimaki-Mogami T; Itoh Y; Ishikawa M; Hashimoto Y; Naito M
    FEBS Lett; 2011 Apr; 585(8):1147-52. PubMed ID: 21414315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation.
    Ohoka N; Morita Y; Nagai K; Shimokawa K; Ujikawa O; Fujimori I; Ito M; Hayase Y; Okuhira K; Shibata N; Hattori T; Sameshima T; Sano O; Koyama R; Imaeda Y; Nara H; Cho N; Naito M
    J Biol Chem; 2018 May; 293(18):6776-6790. PubMed ID: 29545311
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Ohoka N; Okuhira K; Ito M; Nagai K; Shibata N; Hattori T; Ujikawa O; Shimokawa K; Sano O; Koyama R; Fujita H; Teratani M; Matsumoto H; Imaeda Y; Nara H; Cho N; Naito M
    J Biol Chem; 2017 Mar; 292(11):4556-4570. PubMed ID: 28154167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound profiling using a panel of steroid hormone receptor cell-based assays.
    Wilkinson JM; Hayes S; Thompson D; Whitney P; Bi K
    J Biomol Screen; 2008 Sep; 13(8):755-65. PubMed ID: 18753690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
    Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a versatile platform for nuclear receptor screening using AlphaScreen.
    Rouleau N; Turcotte S; Mondou MH; Roby P; Bossé R
    J Biomol Screen; 2003 Apr; 8(2):191-7. PubMed ID: 12844440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of peptide-based chimeric molecules to induce degradation of the estrogen and androgen receptors.
    Yokoo H; Ohoka N; Naito M; Demizu Y
    Bioorg Med Chem; 2020 Aug; 28(15):115595. PubMed ID: 32631565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist.
    Itoh Y; Ishikawa M; Kitaguchi R; Okuhira K; Naito M; Hashimoto Y
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4453-7. PubMed ID: 22658364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coactivator LXXLL nuclear receptor recognition motif.
    Savkur RS; Burris TP
    J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy.
    Demizu Y; Okuhira K; Motoi H; Ohno A; Shoda T; Fukuhara K; Okuda H; Naito M; Kurihara M
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1793-6. PubMed ID: 22277276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of peroxisome proliferator-activated receptor alpha by the ligand.
    Hirotani M; Tsukamoto T; Bourdeaux J; Sadano H; Osumi T
    Biochem Biophys Res Commun; 2001 Oct; 288(1):106-10. PubMed ID: 11594759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner.
    Pendaries V; Verrecchia F; Michel S; Mauviel A
    Oncogene; 2003 Nov; 22(50):8212-20. PubMed ID: 14603262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.